Nucleonics
Office Products Retail & Distribution · 1-10 Employees
View Company Info for Free
Overview
Phone Number
(267) 518-0100Website
www.nucleonicsinc.comRevenue
<$5 MillionIndustry
About Nucleonics
Nucleonics Org Chart
Is Nucleonics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Nucleonics has new funding data
Check if Nucleonics has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Check out if Nucleonics is spiking on competitors!
Nucleonics, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Nucleonics recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Nucleonics
Product Launch: Get notified when Nucleonics launches new products
Click to see if Nucleonics had a recent Job posting/layoffs
Recommended Actions
Reach out to Masked Content who joined Nucleonics as Masked Content
Find more new buyers
Compare Similar Companies to Nucleonics
Compare insights from companies similar to Nucleonics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Nucleonics Tech Stack
A closer look at the technologies used by Nucleonics
Top Office Products Retail & Distribution Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Nucleonics
Nucleonics, founded in January 2001, is an emerging biotechnology company focused on the development of novel RNA interference-based therapeutics for viral and other diseases. The company believes its proprietary technology and delivery systems for expressed interfering RNA offers advantages over other RNAi approaches in terms of safety and efficac... Read More